Rokos Capital Management (UK) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$20.6M |
| 2 |
AGN
Allergan plc
AGN
|
+$6.52M |
| 3 |
SPDR Gold Trust
GLD
|
+$2.78M |
| 4 |
iShares MSCI Mexico ETF
EWW
|
+$1.67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$8.73M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$2.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 4.02% |
| 2 | Communication Services | 0.06% |
| 3 | Technology | 0% |
Similar funds
Rokos Capital Management (UK)'s Q3 2019 Portfolio in Review
As of Q3 2019, Rokos Capital Management (UK) held 11 positions worth $168M, up 637% from $22.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Rokos Capital Management (UK) deployed $147M of net new capital in Q3 2019, opening 6 new positions and adding to 1 existing holding. Its largest new stake was Allergan plc: 40,000 shares worth $6.75M.
By sector, the portfolio is most concentrated in Healthcare at 4% of assets, up from 0% a quarter earlier, followed by Communication Services and Technology.
On the sell side, the most notable exit was Altaba Inc, an estimated $8.73M sold.
- Rokos Capital Management (UK)'s largest Q3 2019 buy was Allergan plc: 40,000 shares worth $6.75M.
- Rokos Capital Management (UK) added most to iShares MSCI Emerging Markets ETF in Q3 2019, an estimated $20.6M increase.
- Rokos Capital Management (UK) fully exited Altaba Inc in Q3 2019, selling an estimated $8.73M.
- Rokos Capital Management (UK)'s ten largest holdings make up 100% of its $168M portfolio in Q3 2019.
- Rokos Capital Management (UK) opened 6 new positions and closed 2 in Q3 2019.
- Rokos Capital Management (UK)'s portfolio value rose 637% quarter-over-quarter to $168M.
Based on Rokos Capital Management (UK)'s 13F filing for Q3 2019, filed 14 Nov 2019.